vs
Side-by-side financial comparison of Honest Company, Inc. (HNST) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($88.0M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -11.8%). Honest Company, Inc. produced more free cash flow last quarter ($18.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 1.0%).
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
HNST vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.0M | $75.5M |
| Net Profit | $-23.6M | — |
| Gross Margin | 15.7% | 69.3% |
| Operating Margin | -27.5% | 22.7% |
| Net Margin | -26.8% | — |
| Revenue YoY | -11.8% | 27.7% |
| Net Profit YoY | -2813.2% | — |
| EPS (diluted) | $-0.21 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.0M | $75.5M | ||
| Q3 25 | $92.6M | $54.5M | ||
| Q2 25 | $93.5M | $52.4M | ||
| Q1 25 | $97.3M | $46.0M | ||
| Q4 24 | $99.8M | $59.1M | ||
| Q3 24 | $99.2M | $80.5M | ||
| Q2 24 | $93.0M | $47.1M | ||
| Q1 24 | $86.2M | $43.8M |
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $758.0K | $8.8M | ||
| Q2 25 | $3.9M | $5.9M | ||
| Q1 25 | $3.3M | $3.0M | ||
| Q4 24 | $-809.0K | — | ||
| Q3 24 | $165.0K | $20.3M | ||
| Q2 24 | $-4.1M | $-4.5M | ||
| Q1 24 | $-1.4M | $-4.8M |
| Q4 25 | 15.7% | 69.3% | ||
| Q3 25 | 37.3% | 77.7% | ||
| Q2 25 | 40.4% | 76.5% | ||
| Q1 25 | 38.7% | 77.1% | ||
| Q4 24 | 38.8% | 76.4% | ||
| Q3 24 | 38.7% | 63.9% | ||
| Q2 24 | 38.3% | 77.4% | ||
| Q1 24 | 37.0% | 75.5% |
| Q4 25 | -27.5% | 22.7% | ||
| Q3 25 | 0.3% | 17.6% | ||
| Q2 25 | 3.1% | 12.7% | ||
| Q1 25 | 2.6% | 8.7% | ||
| Q4 24 | -1.0% | 22.6% | ||
| Q3 24 | 0.1% | 27.4% | ||
| Q2 24 | -4.3% | -4.6% | ||
| Q1 24 | -1.5% | -5.3% |
| Q4 25 | -26.8% | — | ||
| Q3 25 | 0.8% | 16.2% | ||
| Q2 25 | 4.1% | 11.2% | ||
| Q1 25 | 3.3% | 6.5% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 0.2% | 25.2% | ||
| Q2 24 | -4.4% | -9.6% | ||
| Q1 24 | -1.6% | -11.0% |
| Q4 25 | $-0.21 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.03 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.01 | $0.40 | ||
| Q3 24 | $0.00 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.6M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $169.7M | $130.3M |
| Total Assets | $225.4M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.6M | $97.5M | ||
| Q3 25 | $71.5M | $94.4M | ||
| Q2 25 | $72.1M | $96.0M | ||
| Q1 25 | $72.8M | $93.2M | ||
| Q4 24 | $75.4M | $101.0M | ||
| Q3 24 | $53.4M | $96.7M | ||
| Q2 24 | $36.6M | $96.8M | ||
| Q1 24 | $33.6M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $169.7M | $130.3M | ||
| Q3 25 | $190.2M | $115.3M | ||
| Q2 25 | $187.0M | $104.7M | ||
| Q1 25 | $180.4M | $97.1M | ||
| Q4 24 | $174.3M | $92.1M | ||
| Q3 24 | $133.9M | $71.1M | ||
| Q2 24 | $129.7M | $48.5M | ||
| Q1 24 | $124.8M | $51.0M |
| Q4 25 | $225.4M | $216.3M | ||
| Q3 25 | $241.5M | $202.9M | ||
| Q2 25 | $249.0M | $194.9M | ||
| Q1 25 | $265.3M | $196.2M | ||
| Q4 24 | $247.4M | $213.3M | ||
| Q3 24 | $209.2M | $220.7M | ||
| Q2 24 | $200.2M | $205.0M | ||
| Q1 24 | $198.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $14.4M |
| Free Cash FlowOCF − Capex | $18.1M | $14.4M |
| FCF MarginFCF / Revenue | 20.5% | 19.1% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.6M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $14.4M | ||
| Q3 25 | $-504.0K | $9.7M | ||
| Q2 25 | $-745.0K | $14.1M | ||
| Q1 25 | $-2.9M | $3.6M | ||
| Q4 24 | $-16.8M | $15.6M | ||
| Q3 24 | $15.1M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $336.0K | $11.2M |
| Q4 25 | $18.1M | $14.4M | ||
| Q3 25 | $-624.0K | $9.7M | ||
| Q2 25 | $-826.0K | $14.1M | ||
| Q1 25 | $-3.0M | $3.6M | ||
| Q4 24 | $-17.2M | $15.6M | ||
| Q3 24 | $15.0M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $260.0K | — |
| Q4 25 | 20.5% | 19.1% | ||
| Q3 25 | -0.7% | 17.7% | ||
| Q2 25 | -0.9% | 26.8% | ||
| Q1 25 | -3.1% | 7.7% | ||
| Q4 24 | -17.2% | 26.4% | ||
| Q3 24 | 15.1% | 13.7% | ||
| Q2 24 | 3.1% | 2.1% | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.66× | 1.10× | ||
| Q2 25 | -0.19× | 2.41× | ||
| Q1 25 | -0.90× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 91.42× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
